Proinflammatory actions of angiotensins

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 3, 2001, Pages 321-329

  Ruiz Ortega, Marta ^a   Lorenzo, Oscar ^a   Suzuki, Yusuke ^a   Rupérez, Mónica ^a   Egido, Jesús ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; VASCULOTROPIN;

ATHEROSCLEROSIS; CELL PROLIFERATION; CHEMOTAXIS; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; KIDNEY INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; HUMANS; INFLAMMATION; RENIN-ANGIOTENSIN SYSTEM;

EID: 0035022842     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200105000-00005     Document Type: Review

References (109)

1. Vasoactive hormones and renal sclerosis (Nephrology Forum)
2. Angiotensin II as a renal growth factor
3. Angiotensin II receptors and angiotensin II receptor antagonist
4. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
5. Cytokine actions of angiotensin II
6. Angiontensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor
7. The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II
8. Activation of human peripheral monocytes by angiotensin II
9. Chemotactic response of splenic mononuclear cells to angiotensin II in murine schistosomiasis
10. Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells
11. Angiotensin II stimulation of granuloma macrophages phagocytosis and actin polymerization in murine schistosomiasis mansoni
12. Captopril inhibits the proliferacion of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures
13. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
14. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
15. Regulation of U-937 monocyte adhesion to cultured human mesangial cells by cytokines and vasoactive agents
16. Angiotensin II increases monocyte binding to endothelial cells
17. Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo
18. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin
19. Angiotensin II and bradykinin regulate the expression of P-selectin on the surface of endothelial cells in culture
20. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo
21. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
22. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT1 and AT2 receptor-mediated P-selectin unregulation
23. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension
24. Hypertension-induced end-organ damage: A new transgenic approach to an old problem
25. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure
26. Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with mioroalbuminuria
27. 1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats
28. Angiotensin converting enzyme inhibition prevents arterial NF-κB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
29. Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 gene expression
30. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
31. ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
32. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
33. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases
34. The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G
35. Leukocytes synthesize angiotensinogen
36. Angiotensin II generation at the cell surface of activated neutrophils: Novel cathepsin G-mediated catalytic activity that is resistant to inhibition
37. Identification of a human neutrophil angiotension II-generating protease as cathepsin G
38. Mechanisms for inducible control of angiotensinogen gene transcription
39. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
40. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
41. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells
42. Monocyte- and cytokine-induced downregulation of angiotensin-converting enzyme in cultured human and porcine endothelial cells
43. Preactivated peripheral blood monocytes in patients with essential hypertension
44. Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells
45. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells
46. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors
47. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production
48. Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells
49. Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals
50. The effect of captopril on histamine release from purified rat mast cells
51. The effect of central angiotensin II receptor blockade on interleukin-1beta- and prostaglandin E-induced fever in rats: Possible involvement of brain angiotensin II receptor in fever induction
52. Cytokine- and endotoxin-induced nitric oxide synthase in rat astroglial cultures: Differential modulation by angiotensin II
53. Molecular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
54. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
55. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis
56. ACE-inhibitors and atherosclerosis
57. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment
58. The renin angiotensin aldosterone system: A specific target for hypertension management
59. 2 on the production of matrix metalloproteinase by human aortic smooth muscle cells
60. Atherogenesis and inflammation
61. Atherosclerosis - An inflammatory disease
62. Inhibition of early atherogenesis by Iosartan in monkeys with diet-induced hypercholesterolemia
63. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition
64. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats
65. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II induced hypertension
66. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells
67. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells
68. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions
69. Increased leukotriene A(4) hydrolase expression in the heart of angiotensin II-induced hypertensive rat
70. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
71. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis
72. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis
73. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis
74. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice
75. Renal injury from angiotensin II-mediated hypertension
76. 2 receptors in the kidney
77. Angiotensin peptides and inducible transcription factors
78. 1 receptor
79. Angiotensin II induction of fibronectin biosynthesis in cultured human mesangial cells: Association with CREB transcription factor activation
80. 2 receptors in cultured vascular smooth muscle cells. Molecular mechanisms
81. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress
82. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes
83. 1 knockout mice
84. Nuclear factor-κB. A pivotal transcription factor in chronic inflammatory diseases
85. Transcription factor-κB and cardiovascular disease
86. Expression of nuclear factor kappa B (NF-κB) assessed by Southwestern Histochemistry (SWH) is associated with renal injury in IgA nephropathy (IgAN)
87. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats
88. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation
89. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
90. 2 receptors in the differential interaction between angiotensin II or III and alpha-2 adrenoceptors in the nucleus reticularis gigantocellularis in cardiovascular regulation and antinociception in rats
91. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
92. 1 receptor inhibition on chemoattractant and ahdesion molecule synthesis
93. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase
94. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
95. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects
96. Amelioration of angiotensin II-induced cardiac injury by HMG-CoA reductase inhibition
97. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells
98. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats
99. Angiotensin, LDL peroxidation and atherosclerosis
100. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: The potential role of transcription factor NF-kappaB
101. Synthesis and effects of active fragments of angiotensin II
102. Glomerular mRNA expression of angiotensinasa A after renal ablation
103. Angiotensinase A gene expression and activity in isolated glomeruli of diabetic rats
104. Kidney aminopeptidase A and hypertension
105. Proteinuric potentials of angiotensin II, [des-Asp1]-angiotensin II, and [des-Asp1, des-Arg2]-angiotensin II in rats
106. Angiotensin III upregulates genes involved in kidney damage in cultured mesangial cells and renal interstitial fibroblast
107. Angiotensin actions in the kidney: Renewed insight into the old hormone
108. Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes
109. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells